| 中文名称 | (S)-2,6-二氨基-4,5,6,7-四氢苯并噻唑 |
|---|---|
| 中文别名 | (S)-2,6-二氨基-4,5,6,7-四氢苯并噻唑;(6S)-2,6-二氨基-4,5,6,7-四氢苯并噻唑;普拉克索中间体1;普拉克索杂质A;s-2,6-二氨基-4,5,6,7-四氢苯并噻唑;(S)-(-)-2,6-二氨基-4,5,6,7-四氢苯并噻唑;(S)-(-)-2,6-Diamino-4,5,6,7-tetrahydrobenzothiazole (S)-(-)-2,6-二氨基-4,5,6,7-四氢苯并噻唑;(S)-2,6-二氨基-4,5,6,7-四氢苯并噻唑(普拉克索杂质 I);2,6-二氨基-4,5,6,7-四氢苯并噻唑;普拉克索相关物质A USP标准品;普拉克索杂质I;普拉克索中间体;普拉克索相关物质A;)-(-)-2,6-二氨基-4,5,6,7-四氢苯并噻唑;(S)-N-脱丙基普拉克索;普拉克索中五;S-四氯苯并噻唑;普拉克索EP杂质A;普拉克索USP杂质C;普拉克索USP杂质A;盐酸普拉克索EP杂质A;盐酸普拉克索杂质V-摩科提供现货;普拉克索杂质 |
| 英文名称 | (6S)-4,5,6,7-tetrahydro-1,3-benzothiazole-2,6-diamine |
| 英文别名 | (S)-4,5,6,7-Tetrahydrobenzo[d]thiazole-2,6-diamine;(6S)-4,5,6,7-TETRAHYDRO-1,3-BENZOTHIAZOL-2,6-DIAMINE;(6S)-4,5,6,7-TETRAHYDRO-1,3-BENZOTHIAZOLE-2,6-DIAMINE;S-(-)-2,6-Diamino-4,5,6,7-tetrahydrobenzothiazole;(S)-4,5,6,7-TETRAHYDRO-BENZOTHIAZOLE-2,6-DIAMINE;(-)-2,6-diamino-4,5,6,7-tetrahydroben thiazole;(-)-(6S)-2,6-Diamino-4,5,6-tetrahydrobenzothiazole;S(-) 2-Amino-6-amino-4,5,6,7-tetrahydro benzothiazole;S-(-)-2,6-Diamino-4,5,6,7-tetrahydrobenzothiazole (6S)-2,6-Diamino-4,5,6,7-tetrahydrobenzothiazole;(6S)-2,6-Diamino-4,5,6,7-tetrahydrobenzothiazole;(-)-2,6-DIAMINO-4,5,6,7-TETRA-HYDROXYBENZOTHIAZOL;S-(-)-2,6-Diamino-4,5,6,7-tetrahydro-2,6-benzothiazole;(6S)-4,5,6,7-Tetrahydro-2,6-benzothiazolediamine;4,5,6,7-tetrahydrobenzo[d]thiazole-2,6-diamine;(S)-(-)-2,6-Diamino-4,5,6,7-tetrahydrobenzothiazole;(S)-2,6-Diamino-4,5,6,7-tetrahydrobenzothiazole;(S)-4,5,6,7-Tetrahydro-2,6-benzothiazolediamine;(S)-N-Despropyl Pramipexole;2,6-Benzothiazolediamine, 4,5, 6,7-tetrahydro-, (6S)-;Tetrathionicacid,sodiumsalt(1:2);(6S)-4,5,6,7-Tetrahydro-2,6-benzothiazolediamine (S)-4,5,6,7-Tetrahydro-2,6-benzothiazolediamine;(S)-(?)-2,6-Diamino-4,5,6,7-tetrahydrobenzothiazole;2,6-Diamino-4,5,6,7-tetrahydrobenzothiazole;Pramipexole Related Compound A;(S)-4,5,6,7-TETRAHYDROBENZO THIAZOLE-2,6-DIAMINE;PraMipexole IMpurity A;PraMipexole IMpurity C;Pramipexole impurity I;Pramipexole Intermediate 1;PraMipexole EP IMpurity A (USP RC A);Pramipexole Impurity V HCl;J4N3Y41JML;2,6-Diamino-4,5,6,7-tetrahydrobenzothiazole, (S)-;2,6-benzothiazolediamine, 4,5,6,7-tetrahydro-, (6s)-;2,6-B;(S)-4,5,6,7-tetrahydrobenzo[d]thiazole-2,6-diamine;(S)-2,6-Diamino-4,5,6,7-tetrahydrobenzothiazole;(s)-2,6-diamino-4,5,6,7-tetrahydro benzothiazole;DRRYZHHKWSHHFT-BYPYZUCNSA-N;Pramipexole Intermediates;CS-W003372;EN300-208203;(S)-2,6-diamino-4,5,6,7-tetrahvdro benzothiazole;EC 600-715-3;2,6-Diamino-4,5,6,7-tetrahydrobenzothiazole, (-)-;SCHEMBL306889;6-(S)-2,6-Diamino-4,5,6,7-tetrahydrobenzothiazole;(6S)2,6 diamino-4,5,6,7-tetrahydro-benzothiazole;( inverted exclamation markA)-2,6-Diamino-4,5,6,7-tetrahydrobenzothiazole;AC-1609;A13055;CHEMBL1192854;112GI015;DTXSID00893656;(S)-4,5,6,7-Tetrahydrobenzothiazole-2,6-diamine;(-)-(6s)-2,6-diamino-4,5,6,7-tetrahydrobenzothiazole;(6S)-2,6 diamino-4,5,6,7-tetrahydro-benzothiazole;DS-10467;(S)-4,5,6,7-tetrahydro-2,6-benzothiazolediamine, AldrichCPR;(S)-(-)-2,6-Diamino-4,5,6,7-tetrahydrobenzothiazole, 97%;MFCD07368003;Q27281199;2,6-Benzothiazolediamine, 4,5,6,7-tetrahydro-, (S)-;Z1201624020;Pramipexole dihydrochloride monohydrate specified impurity A [EP];D4337;106092-09-5;AKOS005258071;PRAMIPEXOLE DIHYDROCHLORIDE MONOHYDRATE IMPURITY A [EP IMPURITY];UNII-J4N3Y41JML;Pramipexole impurity 7 |
| CAS No. | 106092-09-5 |
| 分子式 | C7H11N3S |
| 分子量 | 169.25 |
4-(2-((2R,3R)-3-(2,5-二氟苯基)-3-羟基-4-(1H-1,2,4-三唑-1-基)丁-2-基)噻唑-4-基)苯甲腈
N-(丁基磺酰基)-O-[4-(4-哌啶基)丁基]-L-酪氨酸盐酸盐一水合物
2-(4-(1-羟基-4-(4-(羟基二苯基甲基)哌啶-1-基)丁基)苯基)-2-甲基丙酸
7-环戊基-N,N-二甲基-2-((5-(哌嗪-1-基)吡啶-2-基)氨基)-7H-吡咯并[2,3-d]嘧啶-6-甲酰胺
(1-((2R,3R,4S,5R)-3,4-二羟基-5-甲基四氢呋喃-2-基)-5-氟-2-氧代-1,2-二氢嘧啶-4-基)氨基甲酸戊酯
((3S,5R)-5-((1H-1,2,4-三唑-1-基)甲基)-5-(2,4-二氟苯基)四氢呋喃-3-基)甲基 4-甲基苯磺酸酯
N-(3-氯-4-氟苯基)-7-甲氧基-6-(3-吗啉-4-丙氧基)喹唑啉-4-胺
(6R,7R)-3-甲基-7-[(R)-2-氨基-2-苯乙酰氨基]-8-氧-5-硫杂-1-双环[4.2.0]辛-2-烯-2-甲酸
(2R,3S,5S)-3-苄氧基-5-[2-[[(4-甲氧基苯基)二苯基甲基]氨基]-6-苄氧基-9H-嘌呤-9-基]-2-苄氧基甲基环戊醇
(2R,3R,4S,5R)-2-(4-氨基吡咯并[2,1-F][1,2,4]三嗪-7-基)-3,4-二羟基-5-(羟甲基)四氢呋喃-2-甲腈
本网站销售的所有产品仅用于工业应用或者科学研究等非医疗目的,不可用于人类或动物的临床诊断或者治疗,非药用,非食用。
CopyRight @2025 广东元丰化学试剂有限公司 版权所有 | 隐私政策 条款及条件 | 粤ICP备2025403430号-1
技术支持:库价化学